Calculated atomic photoeffect cross sections by modified Stobbe theory for atomic number from Z=2 through Z=50, add photon energies between 0.5 keV and 40.0 keV.

Mode of access: Internet.

Organizational, direct and general support, and depot maintenance repair parts and special tools lists : generator set, gasoline engine driven (less engine) 0.5 KW, AC, 120/240V, 60 hertz, 1 PH, Dod model MEP-014A ... DoD model MEP-024A, FSN 6115-940-7867.

"March 1970."

Operator, organizational, intermediate (field), (direct support and general support), and depot maintenance manual : generator sets, gasoline engine driven, 0.5 KW (less engine) : DOD model MEP-014A ....

"October 1977."

Operator, organizational, intermediate (field), (direct support and general support), and depot maintenance manual : generator sets, gasoline engine driven, 0.5 kw (less engine) : DOD model MEP-014A ....

"October 1977."

The thermodynamic properties of helium from 3 to 300⁰ K between 0.5 and 100 atmospheres

Bibliography: p. 13-14.

Numerical modelling of thermal effects in rats due to high-field magnetic resonance imaging (0.5-1 GHz)

A finite-difference time-domain (FDTD) thermal model has been developed to compute the temperature elevation in the Sprague Dawley rat due to electromagnetic energy deposition in high-field magnetic resonance imaging (MRI). The field strengths examined ranged from 11.75-23.5 T (corresponding to H-1 resonances of 0.5-1 GHz) and an N-stub birdcage resonator was used to both transmit radio-frequency energy and receive the MRI signals. With an in-plane resolution of 1.95 mm, the inhomogeneous rat phantom forms a segmented model of 12 different tissue types, each having its electrical and thermal parameters assigned. The steady-state temperature distribution was calculated using a Pennes 'bioheat' approach. The numerical algorithm used to calculate the induced temperature distribution has been successfully validated against analytical solutions in the form of simplified spherical models with electrical and thermal properties of rat muscle. As well as assisting with the design of MRI experiments and apparatus, the numerical procedures developed in this study could help in future research and design of tumour-treating hyperthermia applicators to be used on rats in vivo.

The SECURE study:long-term safety of Ranibizumab 0.5 mg in neovascular age-related macular degeneration

Objective - To evaluate long-term safety of intravitreal ranibizumab 0.5-mg injections in neovascular age-related macular degeneration (nAMD). Design - Twenty-four–month, open-label, multicenter, phase IV extension study. Participants - Two hundred thirty-four patients previously treated with ranibizumab for 12 months in the EXCITE/SUSTAIN study. Methods - Ranibizumab 0.5 mg administered at the investigator's discretion as per the European summary of product characteristics 2007 (SmPC, i.e., ranibizumab was administered if a patient experienced a best-corrected visual acuity [BCVA] loss of >5 Early Treatment Diabetic Retinopathy Study letters measured against the highest visual acuity [VA] value obtained in SECURE or previous studies [EXCITE and SUSTAIN], attributable to the presence or progression of active nAMD in the investigator's opinion). Main Outcome Measures - Incidence of ocular or nonocular adverse events (AEs) and serious AEs, mean change in BCVA from baseline over time, and the number of injections. Results - Of 234 enrolled patients, 210 (89.7%) completed the study. Patients received 6.1 (mean) ranibizumab injections over 24 months. Approximately 42% of patients had 7 or more visits at which ranibizumab was not administered, although they had experienced a VA loss of more than 5 letters, indicating either an undertreatment or that factors other than VA loss were considered for retreatment decision by the investigator. The most frequent ocular AEs (study eye) were retinal hemorrhage (12.8%; 1 event related to study drug), cataract (11.5%; 1 event related to treatment procedure), and increased intraocular pressure (6.4%; 1 event related to study drug). Cataract reported as serious due to hospitalization for cataract surgery occurred in 2.6% of patients; none was suspected to be related to study drug or procedure. Main nonocular AEs were hypertension and nasopharyngitis (9.0% each). Arterial thromboembolic events were reported in 5.6% of the patients. Five (2.1%) deaths occurred during the study, none related to the study drug or procedure. At month 24, mean BCVA declined by 4.3 letters from the SECURE baseline. Conclusions - The SECURE study showed that ranibizumab administered as per a VA-guided flexible dosing regimen recommended in the European ranibizumab SmPC at the investigator's discretion was well tolerated over 2 years. No new safety signals were identified in patients who received ranibizumab for a total of 3 years. On average, patients lost BCVA from the SECURE study baseline, which may be the result of disease progression or possible undertreatment.

Ranibizumab 0.5 mg for diabetic macular edema with bimonthly monitoring after a phase of initial treatment:18-month, multicenter, phase IIIB RELIGHT study

Abstract PURPOSE: To evaluate ranibizumab 0.5 mg using bimonthly monitoring and individualized re-treatment after monthly follow-up for 6 months in patients with visual impairment due to diabetic macular edema (DME). DESIGN: A phase IIIb, 18-month, prospective, open-label, multicenter, single-arm study in the United Kingdom. PARTICIPANTS: Participants (N = 109) with visual impairment due to DME. METHODS: Participants received 3 initial monthly ranibizumab 0.5 mg injections (day 0 to month 2), followed by individualized best-corrected visual acuity (BCVA) and optical coherence tomography-guided re-treatment with monthly (months 3-5) and subsequent bimonthly follow-up (months 6-18). Laser was allowed after month 6. MAIN OUTCOME MEASURES: Mean change in BCVA from baseline to month 12 (primary end point), mean change in BCVA and central retinal thickness (CRT) from baseline to month 18, gain of ≥10 and ≥15 letters, treatment exposure, and incidence of adverse events over 18 months. RESULTS: Of 109 participants, 100 (91.7%) and 99 (90.8%) completed the 12 and 18 months of the study, respectively. The mean age was 63.7 years, the mean duration of DME was 40 months, and 77.1% of the participants had received prior laser treatment (study eye). At baseline, mean BCVA was 62.9 letters, 20% of patients had a baseline BCVA of >73 letters, and mean baseline CRT was 418.1 μm, with 32% of patients having a baseline CRT <300 μm. The mean change in BCVA from baseline to month 6 was +6.6 letters (95% confidence interval [CI], 4.9-8.3), and after institution of bimonthly treatment the mean change in BCVA at month 12 was +4.8 letters (95% CI, 2.9-6.7; P < 0.001) and +6.5 letters (95% CI, 4.2-8.8) at month 18. The proportion of participants gaining ≥10 and ≥15 letters was 24.8% and 13.8% at month 12 and 34.9% and 19.3% at month 18, respectively. Participants received a mean of 6.8 and 8.5 injections over 12 and 18 months, respectively. No new ocular or nonocular safety findings were observed during the study. CONCLUSIONS: The BCVA gain achieved in the initial 6-month treatment period was maintained with an additional 12 months of bimonthly ranibizumab PRN treatment.

The host galaxies and black holes of typical z~0.5-1.4 AGNs

We study the stellar and star formation properties of the host galaxies of 58 X-ray-selected AGNs in the GOODS portion of the Chandra Deep Field South (CDF-S) region at z ~ 0.5-1.4. The AGNs are selected such that their rest-frame UV to near-infrared spectral energy distributions (SEDs) are dominated by stellar emission; i.e., they show a prominent 1.6 μm bump, thus minimizing the AGN emission "contamination." This AGN population comprises approximately 50% of the X-ray-selected AGNs at these redshifts. We find that AGNs reside in the most massive galaxies at the redshifts probed here. Their characteristic stellar masses (M_* ~ 7.8 × 10^10 and M_* ~ 1.2 × 10^11 M_☉ at median redshifts of 0.67 and 1.07, respectively) appear to be representative of the X-ray-selected AGN population at these redshifts and are intermediate between those of local type 2 AGNs and high-redshift (z ~ 2) AGNs. The inferred black hole masses (M_BH ~ 2 × 10^8 M_☉) of typical AGNs are similar to those of optically identified quasars at similar redshifts. Since the AGNs in our sample are much less luminous (L_2–10 keV < 10^44 erg s^−1) than quasars, typical AGNs have low Eddington ratios (η ~ 0.01-0.001). This suggests that, at least at intermediate redshifts, the cosmic AGN "downsizing" is due to both a decrease in the characteristic stellar mass of typical host galaxies and less efficient accretion. Finally, there is no strong evidence in AGN host galaxies for either highly suppressed star formation (expected if AGNs played a role in quenching star formation) or elevated star formation when compared to mass-selected (i.e., IRAC-selected) galaxies of similar stellar masses and redshifts.

Pratiques de soins et négligence infantile : approches narratologique et écologique des récits de parents d'enfants de 0 à 5 ans d'un village bas-laurentien

Thèse numérisée par la Direction des bibliothèques de l'Université de Montréal.

Antarctic ice sheet topography, cavity geometry, and global bathymetry (RTopo 1.0.5-beta)

Sub-ice shelf circulation and freezing/melting rates in ocean general circulation models depend critically on an accurate and consistent representation of cavity geometry. Existing global or pan-Antarctic data sets have turned out to contain various inconsistencies and inaccuracies. The goal of this work is to compile independent regional fields into a global data set. We use the S-2004 global 1-minute bathymetry as the backbone and add an improved version of the BEDMAP topography for an area that roughly coincides with the Antarctic continental shelf. Locations of the merging line have been carefully adjusted in order to get the best out of each data set. High-resolution gridded data for upper and lower ice surface topography and cavity geometry of the Amery, Fimbul, Filchner-Ronne, Larsen C and George VI Ice Shelves, and for Pine Island Glacier have been carefully merged into the ambient ice and ocean topographies. Multibeam survey data for bathymetry in the former Larsen B cavity and the southeastern Bellingshausen Sea have been obtained from the data centers of Alfred Wegener Institute (AWI), British Antarctic Survey (BAS) and Lamont-Doherty Earth Observatory (LDEO), gridded, and again carefully merged into the existing bathymetry map. The global 1-minute dataset (RTopo-1 Version 1.0.5) has been split into two netCDF files. The first contains digital maps for global bedrock topography, ice bottom topography, and surface elevation. The second contains the auxiliary maps for data sources and the surface type mask. A regional subset that covers all variables for the region south of 50 deg S is also available in netCDF format. Datasets for the locations of grounding and coast lines are provided in ASCII format.

Monthly Arctic sea ice lead fraction in 0.5° x 0.5° resolution from SARAL/Altika altimeter, link to datasets in NetCDF 4 format

Sea ice leads play an essential role in ocean-ice-atmosphere exchange, in ocean circulation, geochemistry, and in ice dynamics. Their precise detection is crucial for altimetric estimations of sea ice thickness and volume. This study evaluates the performance of the SARAL/AltiKa (Satellite with ARgos and ALtiKa) altimeter to detect leads and to monitor their spatio-temporal dynamics. We show that a pulse peakiness parameter (PP) used to detect leads by Envisat RA-2 and ERS-1,-2 altimeters is not suitable because of saturation of AltiKa return echoes over the leads. The signal saturation results in loss of 6-10% of PP data over sea ice. We propose a different parameter-maximal power of waveform-and define the threshold to discriminate the leads. Our algorithm can be applied from December until May. It detects well the leads of small and medium size from 200 m to 3-4 km. So the combination of the high-resolution altimetric estimates with low-resolution thermal infra-red or radiometric lead fraction products could enhance the capability of remote sensing to monitor sea ice fracturing.